Skip to main content

Table 1 Purchase volume and expenditures of included antibacterial agents in April to December 2018 and April to December 2019

From: The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis

Categories Volume (million DDDs) Expenditures (million RMB)
Apr. to Dec.
2018
Apr. to Dec.
2019
Relative
change (%)
Apr. to Dec.
2018
Apr. to Dec.
2019
Relative
change (%)
Cefuroxime 1.75 3.38 92.9 5.19 4.21 -18.9
Winning products 1.13 3.20 182.9 1.62 3.29 102.4
Non-winning products 0.62 0.18 -70.3 3.56 0.92 -74.1
Alternatives 7.71 10.04 30.2 87.49 105.89 21.0
Total 9.47 13.42 41.8 92.67 110.09 18.8